Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization

References

• Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, et al. Roles of thrombospondin-1 and −2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci. 2004;45:1117–1124
   PubMed Web of Science ®Google Scholar
• Zhang SX, Ma JX. Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res. 2007;26:1–37
   PubMed Web of Science ®Google Scholar
• Lai CM, Spilsbury K, Brankov M, Zaknich T, Rakoczy PE. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res 2002;75:625–634
   PubMed Web of Science ®Google Scholar
• Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol 2001;12:242–249
   PubMed Web of Science ®Google Scholar
• Epstein RJ, Stulting RD, Hendricks RL, Harris DM. Corneal neovascularization. Pathogenesis and inhibition. Cornea 1987;6:250–257
   PubMed Web of Science ®Google Scholar
• Hanada D, FoIkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353–364
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704–1709
   PubMed Web of Science ®Google Scholar
• Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003;44:3578–3585
   PubMed Web of Science ®Google Scholar
• Tsutsumi-Miyahara C, Sonoda KH, Egashira K, Ishibashi M, Qiao H, Oshima T, et al. The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularization. Br J Ophthalmol 2004;88:1217–1222
   PubMed Web of Science ®Google Scholar
• Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436–445
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121–127
   PubMed Web of Science ®Google Scholar
• Luster AD, Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymusdependent antitumor response in vivo. J Exp Med 1993;178:1057–1065
   PubMed Web of Science ®Google Scholar
• Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993;177:1809–1814
   PubMed Web of Science ®Google Scholar
• Taub DD, Sayers TJ, Carter CR, Ortaldo JR. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995;155:3877–3888
   PubMed Web of Science ®Google Scholar
• Sakthivel SK, Singh UP, Singh S, Taub DD, Novakovic KR, Lillard JW Jr, et al. CXCL10 blockade protects mice from cyclophosphamide-induced cystitis. J Immune Based Ther Vaccines 2008;6:6
   PubMedGoogle Scholar
• Zhang Z, Kaptanoglu L, Tang Y, Ivancic D, Rao SM, Luster A, et al. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. Gastroenterology 2004;126:809–818
   PubMed Web of Science ®Google Scholar
• Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 1998;273:18288–18291
   PubMed Web of Science ®Google Scholar
• Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963–969
   PubMed Web of Science ®Google Scholar
• Luster AD, Greenberg SM, Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995;182:219–231
   PubMed Web of Science ®Google Scholar
• Luster AD, Cardiff RD, MacLean JA, Crowe K, Granstein RD. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians 1998;110:183–196
   PubMedGoogle Scholar
• Yates CC, Whaley D, Kulasekeran P, Hancock WW, Lu B, Bodnar R, et al. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am J Pathol 2007;171:484–495
   PubMed Web of Science ®Google Scholar
• Bodnar RJ, Yates CC, Rodgers ME, Du X, Wells A. IP-10 induces dissociation of newly formed blood vessels. J Cell Sci 2009;122:2064–2077
   PubMed Web of Science ®Google Scholar
• Glaser J, Gonzalez R, Perreau VM, Cotman CW, Keirstead HS. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J Neurosci Res 2004;77:701–708
   PubMed Web of Science ®Google Scholar
• Struyf S, Burdick MD, Peeters E, Van den Broeck K, Dillen C, Proost P, et al. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. Cancer Res 2007;67:5940–5948
   PubMed Web of Science ®Google Scholar
• Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 2003;197:1537–1549
   PubMed Web of Science ®Google Scholar
• Rollins BJ. Chemokines. Blood 1997;90:909–928
   PubMed Web of Science ®Google Scholar
• Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217–242
   PubMed Web of Science ®Google Scholar
• Yates CC, Whaley D, Y-Chen A, Kulesekaran P, Hebda PA, Wells A, et al. ELR-negative CXC chemokine CXCL11 (IP-9/ITAC) facilitates dermal and epidermal maturation during wound repair. Am J Pathol 2008;173:643–652
   PubMed Web of Science ®Google Scholar
• Waeckel L, Mallat Z, Potteaux S, Combadière C, Clergue M, Duriez M, et al. Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. Circ Res 2005;96:576–582
   PubMed Web of Science ®Google Scholar
• Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, et al. CD1drestricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 2003;171:2571–2580
   PubMed Web of Science ®Google Scholar
• Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 1995;210:51–57
   PubMed Web of Science ®Google Scholar
• Bodnar RJ, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 2006;98:617–625
   PubMed Web of Science ®Google Scholar
• Mo FM, Proia AD, Johnson WH, Cyr D, Lashkari K. Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci 2010;51:4226–4236
   PubMed Web of Science ®Google Scholar
• Fujimura S, Takahashi H, Yuda K, Ueta T, Iriyama A, Inoue T, et al. Angiostatic effect of CXCR3 expressed on choroidal neovascularization. Invest Ophthalmol Vis Sci 2012;53:1999–2006
   PubMed Web of Science ®Google Scholar
• Carr DJ, Chodosh J, Ash J, Lane TE. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol 2003;77:10037–10046
   PubMed Web of Science ®Google Scholar
• Lu P, Li L, Kuno K, Wu Y, Baba T, Li YY, et al. Protective roles of the fractalkine/CX3CL1-CX3CR1 axis against alkali-induced corneal neovascularization through enhanced anti-angiogenic factor expression. J Immunol 2008;108:4283–4291
   Google Scholar
• Liu G, Lu P, Li L, Jin H, He X, Mukaida N, et al. Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. Molecular Vision 2011;17:2129–2138
   PubMed Web of Science ®Google Scholar
• Lu P, Li L, Liu G, van Rooijen N, Mukaida N, Zhang X. Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization. Cornea 2009;28:562–569
   PubMed Web of Science ®Google Scholar
• Lu P, Li L, Liu G, Baba T, Ishida Y, Nosaka M, et al. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization. Invest Ophthalmol Vis Sci 2012;53:3516–3526
   PubMed Web of Science ®Google Scholar
• Furuichi K, Gao JL, Murphy PM. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol 2006;169:372–387
   PubMed Web of Science ®Google Scholar
• Barlic J, Zhang Y, Foley JF, Murphy PM. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor γ-dependent pathway. Circulation 2006;114:807–819
   PubMed Web of Science ®Google Scholar
• Tomura K, Narumi S. Differential induction of interferon (IFN)-inducible protein 10 following differentiation of a monocyte, macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites. Int J Mol Med 1999;3:477–484
   PubMed Web of Science ®Google Scholar
• Luster AD, Unkeless JC, Ravetch JV. γ-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985;315:672–676
   PubMed Web of Science ®Google Scholar
• Aronica SM, Raiber L, Hanzly M, Kisela C. Antitumor/antiestrogenic effect of the chemokine interferon inducible protein 10 (IP-10) involves suppression of VEGF expression in mammary tissue. J Interferon Cytokine Res 2009;29:83–92
   PubMed Web of Science ®Google Scholar
• Sato E, Fujimoto J, Tamaya T. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Oncology 2007;73:246–251
   PubMed Web of Science ®Google Scholar
• Sato E, Fujimoto J, Toyoki H, Sakaguchi H, Alam SM, Jahan I, et al. Expression of IP-10 related to angiogenesis in uterine cervical cancers. Br J Cancer 2007;96:1735–1739
   PubMed Web of Science ®Google Scholar
• Nakaya I, Wada T, Furuichi K, Sakai N, Kitagawa K, Yokoyama H, et al. Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. Nephron Exp Nephrol 2007;107:e12–e21
   PubMedGoogle Scholar
• Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, et al. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999;59:3698–3704
   PubMed Web of Science ®Google Scholar